Хайлтын үр дүнгүүд - Hun Ju Lee
- 35-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy -н Preetesh Jain, Loretta J. Nastoupil, Jason R. Westin, Hun Ju Lee, Lucy Navsaria, Raphaël Steiner, Sairah Ahmed, Omar Moghrabi, Onyeka Oriabure, Wendy Chen, Maria Badillo, Christopher R. Flowers, Michael Wang
Хэвлэсэн 2020Carta -
4
Four‐year follow‐up of a single arm, phase <scp>II</scp> clinical trial of ibrutinib with rituximab (<scp>IR</scp>) in patients with relapsed/refractory mantle cell lymphoma (<scp>... -н Preetesh Jain, Jorge Romaguera, Samer A. Srour, Hun Ju Lee, Frederick Hagemeister, Jason R. Westin, Luis Fayad, Felipe Samaniego, Maria Badillo, Liang Zhang, L. Nastoupil, Rashmi Kanagal‐Shamanna, Nathan Fowler, Michael Wang
Хэвлэсэн 2018Artigo -
5
Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma -н Chelsea C. Pinnix, Jillian R. Gunther, Sarah A. Milgrom, R.J. Cruz-Chamorro, L. Jeffrey Medeiros, Joseph D. Khoury, Behrang Amini, Sattva S. Neelapu, Hun Ju Lee, Jason R. Westin, Nathan Fowler, Loretta J. Nastoupil, Bouthaina S. Dabaja
Хэвлэсэн 2019Artigo -
6
PET-Adapted Nivolumab or Nivolumab Plus ICE As First Salvage Therapy in Relapsed or Refractory Hodgkin Lymphoma -н Alex F. Herrera, Robert W. Chen, Joycelynne Palmer, Ni‐Chun Tsai, Matthew Mei, Leslie Popplewell, Auayporn Nademanee, Liana Nikolaenko, Kathryn McBride, Ricardo Ortega, Joo Y. Song, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Hun Ju Lee
Хэвлэсэн 2019Artigo -
7
hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies -н Miguel Gallardo, Hun Ju Lee, Xiaorui Zhang, Carlos E. Bueso‐Ramos, Laura R. Pageon, Mark J. McArthur, Asha S. Multani, Aziz Nazha, Taghi Manshouri, Jan Parker‐Thornburg, Inmaculada Rapado, Alfonso Quintás‐Cardama, Steven M. Kornblau, Joaquín Martínez‐López, Sean M. Post
Хэвлэсэн 2015Artigo -
8
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy -н Ajlan Al Zaki, Lei Feng, Grace Watson, Sairah Ahmed, Haleigh Mistry, Loretta J. Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P. Iyer, Hun Ju Lee, Raphaël Steiner, Christopher R. Flowers, Elizabeth J. Shpall, Partow Kebriaei, Sattva S. Neelapu, Jason R. Westin, Paolo Strati
Хэвлэсэн 2022Artigo -
9
Management strategies and outcomes for very elderly patients with diffuse large B‐cell lymphoma -н Dai Chihara, Jason R. Westin, Yasuhiro Oki, Mohamed Ahmed, Bryan Do, Luis Fayad, Fredrick B. Hagemeister, Jorge Romaguera, Michelle A. Fanale, Hun Ju Lee, Francesco Turturro, Felipe Samaniego, Sattva S. Neelapu, Maria Alma Rodriguez, Nathan Fowler, Michael Wang, R. Eric Davis, Loretta J. Nastoupil
Хэвлэсэн 2016Artigo -
10
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087 -н Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, Philippe Armand, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Jianxin Lin, Eunhee Kim, Akash Nahar, Arun Balakumaran, Craig H. Moskowitz
Хэвлэсэн 2019Artigo -
11
Long‐term survival among 5‐year survivors of adolescent and young adult cancer -н Amy M. Berkman, J. Andrew Livingston, Kelly W. Merriman, Michelle A.T. Hildebrandt, Jian Wang, Seyedeh Dibaj, Jennifer L. McQuade, Nancy You, Anita K. Ying, Carlos H. Bárcenas, Diane C. Bodurka, April DePombo, Hun Ju Lee, John de Groot, Michael Roth
Хэвлэсэн 2020Artigo -
12
Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma -н Paolo Strati, Ankur Varma, Sherry Adkins, Loretta J. Nastoupil, Jason R. Westin, Fredrick B. Hagemeister, Nathan Fowler, Hun Ju Lee, Luis Fayad, Felipe Samaniego, Sairah Ahmed, Yiming Chen, Sandra Horowitz, Sara Arafat, Swapna Johncy, Partow Kebriaei, Victor E. Mulanovich, Ella Ariza‐Heredia, Sattva S. Neelapu
Хэвлэсэн 2020Artigo -
13
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma -н Philippe Armand, Pier Luigi Zinzani, Hun Ju Lee, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Alex F. Herrera, Jianxin Lin, Eunhee Kim, Samhita Chakraborty, Patricia Marinello, Craig H. Moskowitz
Хэвлэсэн 2023Artigo -
14
Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high‐risk relapsed/refractory Hodgkin lymphoma -н Matthew Mei, Joycelynne Palmer, Hun Ju Lee, Iris Isufi, Robert Chen, Ni‐Chun Tsai, Saro H. Armenian, James L. Godfrey, Joo Y. Song, John H. Baird, Swetha Kambhampati, Yazeed Samara, Jessica Flores, Lacolle Peters, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Alex F. Herrera
Хэвлэсэн 2025Artigo -
15
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma -н Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Paolo Strati, Penny Fang, Misha Hawkins, Sherry Adkins, Jason R. Westin, Sairah Ahmed, Luis Fayad, Hun Ju Lee, Ranjit Nair, Raphaël Steiner, Swaminathan P. Iyer, Maria Alma Rodriguez, Michael Wang, Christopher R. Flowers, Sattva S. Neelapu, Loretta J. Nastoupil
Хэвлэсэн 2020Artigo -
16
Low 25(OH) vitamin D<sub>3</sub> levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia -н Hun Ju Lee, Josephia R. Muindi, Wei Phin Tan, Qiang Hu, Dan Wang, Song Liu, Gregory E. Wilding, Laurie Ford, Sheila N.J. Sait, AnneMarie W. Block, Araba A. Adjei, Maurice Barcos, Elizabeth A. Griffiths, James E. Thompson, Eunice S. Wang, Candace S. Johnson, Donald L. Trump, Meir Wetzler
Хэвлэсэн 2013Artigo -
17
Pre‐treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma -н Jay P. Reddy, Mike Hernández, Jillian R. Gunther, Bouthaina S. Dabaja, Geoffrey V. Martin, Wen Jiang, Mani Akhtari, Pamela K. Allen, Bradley J. Atkinson, Grace L. Smith, Chelsea C. Pinnix, Sarah A. Milgrom, Zeinab Abou Yehia, E.M. Osborne, Yasuhiro Oki, Hun Ju Lee, Fredrick B. Hagemeister, Michelle A. Fanale
Хэвлэсэн 2017Artigo -
18
Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study -н Radhakrishnan Ramchandren, Eva Domingo‐Domènech, Antonio Rueda, Marek Trněný, Tatyana Feldman, Hun Ju Lee, Mariano Provencio, Christian Sillaber, Jonathon B. Cohen, Kerry J. Savage, Wolfgang Willenbacher, Azra H. Ligon, Jing Ouyang, Robert Redd, Scott J. Rodig, Margaret A. Shipp, Mariana Sacchi, Anne Sumbul, Philippe Armand, Stephen M. Ansell
Хэвлэсэн 2019Artigo -
19
The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma -н Dai Chihara, Michelle A. Fanale, Roberto N. Miranda, Mansoor Noorani, Jason R. Westin, Loretta J. Nastoupil, Fredrick B. Hagemeister, Luis Fayad, Jorge Romaguera, Felipe Samaniego, Francesco Turturro, Hun Ju Lee, Sattva S. Neelapu, Maria Alma Rodriguez, Michael Wang, Nathan Fowler, R. Eric Davis, L. Jeffrey Medeiros, Chitra Hosing, Yago Nieto, Yasuhiro Oki
Хэвлэсэн 2016Artigo -
20
Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma -н Chelsea C. Pinnix, Bouthaina S. Dabaja, Sarah A. Milgrom, Grace L. Smith, Zeinab Abou, Loretta J. Nastoupil, Jorge Romaguera, Francesco Turturro, Nathan Fowler, Luis Fayad, Jason R. Westin, Sattva S. Neelapu, Michelle A. Fanale, Maria Alma Rodriguez, Frederick Hagemeister, Hun Ju Lee, Yasuhiro Oki, Michael Wang, Felipe Samaniego, Linda Chi, Bita Esmaeli
Хэвлэсэн 2017Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Lymphoma
Oncology
Gastroenterology
Cancer
Surgery
Biology
Chemotherapy
Immunotherapy
Immunology
Astrobiology
Refractory (planetary science)
Leukemia
Mantle cell lymphoma
Physics
Rituximab
Chronic lymphocytic leukemia
Gene
Hodgkin lymphoma
Ibrutinib
Nivolumab
Biochemistry
Cancer research
Clinical trial
Genetics
Myeloid leukemia
Salvage therapy
Adverse effect
Chimeric antigen receptor